Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 63 | ECE2019 | Next issue

21st European Congress of Endocrinology

Lyon, France
18 May 2019 - 21 May 2019

Card image cap
18-21 May 2019, Lyon, France

Poster Presentations

Diabetes, Obesity and Metabolism 2

Previous section
Calcium and Bone 2
Table of contents
Next section
Interdisciplinary Endocrinology 1

ea0063p526 | Diabetes, Obesity and Metabolism 2

Hypoglycemia as a first symptom of fructosemia, complicated by gestational diabetes in III pregnancy and 26 years of delayed final diagnosis: a case report

ea0063p527 | Diabetes, Obesity and Metabolism 2

Artificial intelligence for the remote evaluation of gestational diabetes using a smartphone application (Sinedie©): Study design.

ea0063p528 | Diabetes, Obesity and Metabolism 2

Adolescent type 1 diabetes self-management: what about dietary regimen?

ea0063p529 | Diabetes, Obesity and Metabolism 2

Epicardial fat accumulation in non-alcoholic liver disease and impaired glucose metabolism

ea0063p530 | Diabetes, Obesity and Metabolism 2

Vitamin B12 and gestational diabetes mellitus

ea0063p531 | Diabetes, Obesity and Metabolism 2

TRMA syndrome (thiamine-responsive megaloblastic anemia): a case report

ea0063p532 | Diabetes, Obesity and Metabolism 2

Study on efficacy of long-term education for achieving compensation of type 1 diabetes mellitus in children Almaty region of Kazakhstan

ea0063p533 | Diabetes, Obesity and Metabolism 2

A novel oral pyruvate dehydrogenase kinase 4 inhibitor ameliorates various spectrum of metabolic diseases in mice

ea0063p534 | Diabetes, Obesity and Metabolism 2

Quality of life in patients undergoing bariatric surgery

ea0063p535 | Diabetes, Obesity and Metabolism 2

Metabolic encephalopathy secondary to diabetic ketoacidosis

ea0063p536 | Diabetes, Obesity and Metabolism 2

Maternal weight status and gestational diabetes

ea0063p537 | Diabetes, Obesity and Metabolism 2

Diabetic retinopathy: Prevalence and risk factors

ea0063p538 | Diabetes, Obesity and Metabolism 2

Efficacy of plasmapheresis in the management of severe hypertriglyceridemia

ea0063p539 | Diabetes, Obesity and Metabolism 2

Insulin pump therapy in patients with type 1 diabetes in Morocco

ea0063p540 | Diabetes, Obesity and Metabolism 2

Role of proinflammatory cytokines TNF-α and IL-6 in pathogenesis of type 2 diabetes mellitus in persons exposed to ionizing radiation after the Chernobyl NPP accident

ea0063p541 | Diabetes, Obesity and Metabolism 2

A case of DRESS syndrome associated with autoimmune type 1 diabetes

ea0063p542 | Diabetes, Obesity and Metabolism 2

Examination of the care pathways of adults with diabetes undergoing haemodialysis for end stage renal failure

ea0063p543 | Diabetes, Obesity and Metabolism 2

Exploratory study into communication styles of diabetes healthcare professionals according to their patients numerical ability

ea0063p544 | Diabetes, Obesity and Metabolism 2

Enterotypes of the gut microbiome in Russian population and their metabolic activity

ea0063p545 | Diabetes, Obesity and Metabolism 2

Lipid profile and cardiovascular risk in ankylosing spondylitis

ea0063p546 | Diabetes, Obesity and Metabolism 2

Diagnostics of carbohydrate metabolism according to the regularity of menstrual cycle

ea0063p547 | Diabetes, Obesity and Metabolism 2

Clinical characteristics and foot amputations rate in patients treated in a multidisciplinary diabetic foot unit

ea0063p548 | Diabetes, Obesity and Metabolism 2

Microbiota changes in type 2 diabetes patients intolerant to metformin after drug reintroduction

ea0063p549 | Diabetes, Obesity and Metabolism 2

PRIMAVERA study: sibutramine therapy safety monitoring in patients with obesity

ea0063p550 | Diabetes, Obesity and Metabolism 2

Does therapeutic education really prevent lipodystrophy?

ea0063p551 | Diabetes, Obesity and Metabolism 2

Insulin injection techniques: what do moroccan diabetic patients do?

ea0063p552 | Diabetes, Obesity and Metabolism 2

The reuse of insulin needles: a problem with consequences (about 1000 cases)

ea0063p553 | Diabetes, Obesity and Metabolism 2

Polymorphisms of genes GNB3, SERT, NET, TPH2 and results of obesity treatment with sibutramine

ea0063p554 | Diabetes, Obesity and Metabolism 2

Microcirculatory disorders in adolescents with tipe 1 diabetes mellitus

ea0063p555 | Diabetes, Obesity and Metabolism 2

Therapeutic and nutritional compliance in diabetic patients in the Endocrinology-Diabetology-Nutrition Department of Mohammed VI University Hospital Center in Oujda

ea0063p556 | Diabetes, Obesity and Metabolism 2

Diabetes increases liver fibroscan value regardless of steatosis

ea0063p557 | Diabetes, Obesity and Metabolism 2

Tobacco and diabetes: a comparative study of smoking diabetic patients and non-smoking diabetic patients in the Endocrinology-Diabetology-Nutrition Department of Oujda’s University Hospital in Morocco

ea0063p558 | Diabetes, Obesity and Metabolism 2

Endocrinopathies and diabetes: cardiovascular risk assessment

ea0063p559 | Diabetes, Obesity and Metabolism 2

Inflammation and adipocytokines in overweight and obesity

ea0063p560 | Diabetes, Obesity and Metabolism 2

Free T3 correlates with iron metabolism indexes in patients with type 1 diabetes and diabetic kidney disease

ea0063p561 | Diabetes, Obesity and Metabolism 2

Features of type 2 diabetes mellitus in the elderly (Minsk)

ea0063p562 | Diabetes, Obesity and Metabolism 2

The role of glucagon like peptide - 1 (GLP-1) receptor agonists in the treatment of type 2 diabetes mellitus

ea0063p563 | Diabetes, Obesity and Metabolism 2

Autoimmune diabetes mellitus adult patients having latent autoimmune diabetes of adulthood (LADA) form exhibit different prevalence of accompanying autoimmune diseases than patients with conventional (juvenile) autoimmune type 1 diabetes: Furthermore, anti-GAD autoantibodies are strongly associated with accompanying autoimmune diseases in patients with autoimmune diabetes mellitus

ea0063p564 | Diabetes, Obesity and Metabolism 2

Erythrocytes glucose uptake increases in rats with experimental induced obesity, diabetes and hyperinsulinemia

ea0063p565 | Diabetes, Obesity and Metabolism 2

Giant prolactinoma associated with alopecia universalis (AU): a case report

ea0063p566 | Diabetes, Obesity and Metabolism 2

Evaluation of the improvement in vascular endothelial function from raphanus sativus via activation of PI3K/Akt pathway

ea0063p567 | Diabetes, Obesity and Metabolism 2

Cardiovascular risk in obese women with polycystic ovary syndrome using Framingham scoring system

ea0063p568 | Diabetes, Obesity and Metabolism 2

Association Kidney Neoplasm and recent diabetes: think about MODY 5

ea0063p569 | Diabetes, Obesity and Metabolism 2

Body composition (DXA) and hormonal picture in obese children

ea0063p570 | Diabetes, Obesity and Metabolism 2

Mineralocorticoid receptor and diabetes: in favour of other corticosteroids than aldosterone

ea0063p571 | Diabetes, Obesity and Metabolism 2

Abstract unavailable

ea0063p572 | Diabetes, Obesity and Metabolism 2

Erythrocytes membrane plasmalogens level in Diabetes Mellitus depends from Arterial Hypertension and nephropathy

ea0063p573 | Diabetes, Obesity and Metabolism 2

A hyperglycemic crisis as a first appearance of newly onset diabetes mellitus in a patient using dexamethasone: Blame the usual suspect or accuse a new one?

ea0063p574 | Diabetes, Obesity and Metabolism 2

Use of insulin therapy in the treatment of gestational diabetes

ea0063p575 | Diabetes, Obesity and Metabolism 2

The fasting of diabetic patients during Ramadan: a dilemma of religious conviction and medical prohibition

ea0063p576 | Diabetes, Obesity and Metabolism 2

Myocardial infarction in diabetic patients and cardiovascular risk factors control

ea0063p577 | Diabetes, Obesity and Metabolism 2

Comparison of effects of metformin used as a monotherapy or in combination with gliclazide MR on glycemic control and lipid profile in patients with type 2 diabetes mellitus

ea0063p578 | Diabetes, Obesity and Metabolism 2

Factors affecting effective gestational diabetes mellitus management: six-year experience from a single tertiary center

ea0063p579 | Diabetes, Obesity and Metabolism 2

Oral glucose tolerance test is recommended for screening for new-onset glucose metabolism impairment during chronic low-dose glucocorticoid therapy

ea0063p580 | Diabetes, Obesity and Metabolism 2

Incidence of diabetes and its predictive factors in cancer patients treated with phosphatidylinositol 3 kinase inhibitors

ea0063p581 | Diabetes, Obesity and Metabolism 2

Flash glucose monitoring: repercussions in glycemic control

ea0063p582 | Diabetes, Obesity and Metabolism 2

The role of proper insulin injection technique to achieve optimal glycemic control

ea0063p583 | Diabetes, Obesity and Metabolism 2

Metabolic effects of a novel myokine, Follistatin like protein 1 (FSTL1), in human primary adipocytes

ea0063p584 | Diabetes, Obesity and Metabolism 2

Discordance between body-mass index and body adiposity index in classification of adiposity status in the elderly

ea0063p585 | Diabetes, Obesity and Metabolism 2

The effect of Iranian propolis on glucose metabolism, lipid profile, insulin resistance, renal function and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double blind clinical trial

ea0063p586 | Diabetes, Obesity and Metabolism 2

Real-world experience of generalized and partial lipodystrophy patients enrolled in the metreleptin early access program

ea0063p587 | Diabetes, Obesity and Metabolism 2

Prevalence and characteristics of Nivolumab-induced diabetes: results from a monocentric observational study

ea0063p588 | Diabetes, Obesity and Metabolism 2

Genetic diagnosis of maturity-onset diabetes of the young (MODY): experience of diabetology-endocrinology department of Oujda’s Mohammed VI university hospital

ea0063p589 | Diabetes, Obesity and Metabolism 2

Discrete choice and SF-36 estimates of patient quality of life and benefits of leptin replacement therapy (LRT) in generalized and partial lipodystrophy (GL, PL)

ea0063p590 | Diabetes, Obesity and Metabolism 2

Are all hypoglycemic drugs similar for men with type 2 diabetes and testosterone deficiency?

ea0063p591 | Diabetes, Obesity and Metabolism 2

A 5-years postoperative upper digestive endoscopy in obesity surgery

ea0063p592 | Diabetes, Obesity and Metabolism 2

Occupational outcomes after bariatric surgery: relation to deprivation, satisfaction score

ea0063p593 | Diabetes, Obesity and Metabolism 2

Probiotic supplementation and β-cell function in type 2 diabetes: evidence from randomized clinical trial

ea0063p594 | Diabetes, Obesity and Metabolism 2

Relationship between lipid profile and uricemia in diabetic type 2

ea0063p595 | Diabetes, Obesity and Metabolism 2

Insulin resistance, systemic and regional inflammation in subcutaneous adipose tissue during weight loss in a population with obesity

ea0063p596 | Diabetes, Obesity and Metabolism 2

The effect of 3 months of daily consumption of sugar-sweetened beverages on liver, adipose tissue, and glucose metabolism in an animal study

ea0063p597 | Diabetes, Obesity and Metabolism 2

A new neurocognitive phenotype in Alstrom sindrome

ea0063p598 | Diabetes, Obesity and Metabolism 2

Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit

ea0063p599 | Diabetes, Obesity and Metabolism 2

Testosterone restores metabolic syndrome-induced impairement in physical activity by ameliorating skeletal muscle fiber metabolism

ea0063p600 | Diabetes, Obesity and Metabolism 2

Compliance with gestational weight gain in women with gestational diabetes mellitus

ea0063p601 | Diabetes, Obesity and Metabolism 2

Clinical and ultrasonographic characteristics of women with co-existing gestational diabetes mellitus and thyroid disease

ea0063p602 | Diabetes, Obesity and Metabolism 2

Platelet reactivity in patients with type 2 diabetes mellitus after treatment intensification with DPP-4i, SGLT-2i and GLP-1RA

ea0063p603 | Diabetes, Obesity and Metabolism 2

Renoprotective effects of weekly dulaglutide in type 2 diabetes patients: A routine clinical practice study

ea0063p604 | Diabetes, Obesity and Metabolism 2

The effects of testosterone treatment on fat tissue dysfunction and nonalcoholic fatty liver disease in obese men undergoing bariatric surgery

ea0063p605 | Diabetes, Obesity and Metabolism 2

Parabens and their relationship to obesity

ea0063p606 | Diabetes, Obesity and Metabolism 2

Complex use of noninvasive methods for estimating microcirculation of the blood and oxidative metabolism on the big sting finger in patients with diabetes, such as permeable diagnostic diagnostics diagnostics, patients with diable diagnosis

ea0063p607 | Diabetes, Obesity and Metabolism 2

Liver fibrosis and steatosis severity evaluation in patients with chronic hepatitis C and type 2 diabetes mellitus

ea0063p608 | Diabetes, Obesity and Metabolism 2

Determinant factors for prescription of antidiabetic drugs with beneficial effects on weight

ea0063p609 | Diabetes, Obesity and Metabolism 2

Gut microbiota pattern in relation to diet, physical activity and malnutrition in patients with inflammatory bowel disease: cases-control study

ea0063p610 | Diabetes, Obesity and Metabolism 2

Description of a novel AGPAT2 gene mutation (R159C) responsible for congenital generalized lipoatrophy type 1 (Berardinelli-Seip Syndrome)

ea0063p611 | Diabetes, Obesity and Metabolism 2

Prenatal metformin treatment in obese rats: Evaluation of liver norepinephrine and lipogenic enzymes in offspring

ea0063p612 | Diabetes, Obesity and Metabolism 2

Profile of celiac disease in diabetic children

ea0063p613 | Diabetes, Obesity and Metabolism 2

A common but forgotten cause of electrolyte disturbances in patients with cachexia

ea0063p614 | Diabetes, Obesity and Metabolism 2

Vitamin D status and bone metabolism in adult patients with Type 1 diabetes mellitus

ea0063p615 | Diabetes, Obesity and Metabolism 2

The effect of antidiabetic drugs on serum 25-hydroxyvitamin D level: A preliminary report

ea0063p616 | Diabetes, Obesity and Metabolism 2

Serum total and bioactive fibroblast growth factor 21 levels are similar in patients with gestational diabetes mellitus and healthy pregnant controls

ea0063p617 | Diabetes, Obesity and Metabolism 2

Liraglutide restores the hyperglycemic oxidative imbalance and induces the expression of CRH, UCN1, UCN2 AND UCN3 neuropeptides in macroendothelial cells

ea0063p618 | Diabetes, Obesity and Metabolism 2

The effects of hyperinsulinemia on cochlear functions

ea0063p619 | Diabetes, Obesity and Metabolism 2

Trial-in-progress: ZEPHYR, a pivotal phase 2b/3 randomized, placebo-controlled study of livoletide, a novel unacylated ghrelin analog, for the treatment of hyperphagia and food-related behaviors in patients with Prader-Willi syndrome

ea0063p620 | Diabetes, Obesity and Metabolism 2

Next generation sequencing reveals ABCC8 (MODY 12) variants in two families with diabetes mellitus (DM)

ea0063p621 | Diabetes, Obesity and Metabolism 2

Nonclinical development of livoletide (AZP-531), a peptide analog of unacylated ghrelin for the treatment of hyperphagia in Prader-Willi syndrome

ea0063p622 | Diabetes, Obesity and Metabolism 2

Assessment of materno-fetal complications in pregnant women with type 1 diabetes exposed to insulin degludec

ea0063p623 | Diabetes, Obesity and Metabolism 2

Myeloproliferative disorder: a rare cause of insulin auto-immune syndrome leading to recurrent severe hypoglycaemia

ea0063p624 | Diabetes, Obesity and Metabolism 2

Augmented Mitophagy and Inflammasome Activation with Metformin therapy in patients with T2DM

ea0063p625 | Diabetes, Obesity and Metabolism 2

Features of IL-17 expression in focus of inflammation modulating in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more